Acer Therapeutics OverviewAcer Therapeutics EBIT
EBIT (Earnings Before Interest and Taxes) analysis for ACER.
Quarterly EBIT
-$12.88M
↓ 145.81% YoY
As of Sep 30, 2023
Annual EBIT (TTM)
-$13.86M
↑ 49.74% YoY
Trailing 12 months ending Sep 30, 2023
Acer Therapeutics OverviewEBIT (Earnings Before Interest and Taxes) analysis for ACER.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023